Dr. Collinge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1086 Elm St Ste 101a
Rocky Hill, CT 06067Phone+1 860-453-0545Fax+1 860-359-2540
Education & Training
MedStar Health/Georgetown-Washington Hospital CenterResidency, Ophthalmology, 2009 - 2012
Christiana Care Health ServicesInternship, Transitional Year, 2008 - 2009
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
MA State Medical License 2021 - 2026
MI State Medical License 2023 - 2026
NY State Medical License 2021 - 2026
CT State Medical License 2019 - 2025
OK State Medical License 2013 - 2020
IN State Medical License 2012 - 2013
DC State Medical License 2009 - 2012- American Board of Ophthalmology Ophthalmology
- Join now to see all
Clinical Trials
- Cerebrotendinous Xanthomatosis (CTX) Prevalence Study Start of enrollment: 2015 Sep 01
Roles: Contact
Publications & Presentations
PubMed
- 6 citationsThe Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results.Stacy L Pineles, Robert J Henderson, Michael X Repka, Gena Heidary, Grant T Liu
Ophthalmology. 2022-08-01 - 39 citationsOutcome of pediatric patients referred for papilledemaJessica Kovarik, Poonam N. Doshi, Janine E. Collinge, David A. Plager
Journal of AAPOS. 2015-08-01 - 13 citationsSecondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of PrematurityEric R. Crouch, Raymond T. Kraker, David K. Wallace, Jonathan M. Holmes, Michael X. Repka
JAMA Ophthalmology. 2020-01-01
Press Mentions
Preventing Eye Strain During Your Child’s Screen-Based LearningJuly 7th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
